Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 321 institutions that hold shares in the stock, with a total of 176 Million shares, which have been reported (via 13F filing form) to have a value of $6.49 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Kohlberg Kravis Roberts & Co. L.P.
New York, NY |
Feb 14, 2025 Q4 2024 |
25,260,971
shares
|
$931 Million
44.98% of portfolio
|
Q3 2024
Reduced 18.67%
|
|
|
Viking Global Investors LP
|
Feb 14, 2025 Q4 2024 |
25,120,991
shares
|
$926 Million
2.33% of portfolio
|
Q3 2023
Reduced 5.63%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
15,077,915
shares
|
$556 Million
0.01% of portfolio
|
Q4 2024
Added 6.19%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
12,448,272
shares
|
$459 Million
0.01% of portfolio
|
Q2 2024
Added 18.93%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,182,627
shares
|
$228 Million
0.01% of portfolio
|
Q4 2024
Added 3.69%
|
|
|
Aisling Capital Management LP
New York, NY |
Feb 12, 2025 Q4 2024 |
6,068,125
shares
|
$224 Million
61.0% of portfolio
|
Q1 2021
Added 52.11%
|
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
4,907,533
shares
|
$181 Million
0.07% of portfolio
|
Q4 2024
Added 1.86%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,195,000
shares
|
$155 Million
0.61% of portfolio
|
Q4 2024
Added 140.13%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
3,800,457
shares
|
$140 Million
6.25% of portfolio
|
Q4 2024
Added 1.06%
|
|
|
Laurion Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,740,896
shares
|
$138 Million
1.96% of portfolio
|
Q4 2024
Reduced 3.94%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
3,526,747
shares
|
$130 Million
0.02% of portfolio
|
Q4 2024
Added 34.9%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,417,693
shares
|
$126 Million
0.01% of portfolio
|
Q4 2024
Added 0.11%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
2,794,292
shares
|
$103 Million
0.03% of portfolio
|
Q4 2024
Reduced 1.18%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,532,716
shares
|
$93.3 Million
0.05% of portfolio
|
Q2 2023
Added 75.59%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,211,521
shares
|
$81.5 Million
0.45% of portfolio
|
Q4 2024
Added 132.85%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,035,189
shares
|
$75 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.82%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Feb 13, 2025 Q4 2024 |
1,975,249
shares
|
$72.8 Million
0.1% of portfolio
|
Q4 2024
Added 4.75%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
1,885,794
shares
|
$69.5 Million
0.05% of portfolio
|
Q4 2024
Added 23.08%
|
|
|
Sc Us (Ttgp), Ltd.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,860,364
shares
|
$68.6 Million
0.46% of portfolio
|
Q2 2021
Reduced 26.89%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,839,855
shares
|
$67.8 Million
0.01% of portfolio
|
Q4 2024
Added 69.29%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,807,472
shares
|
$66.6 Million
0.06% of portfolio
|
Q4 2024
Reduced 35.52%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,600,000
shares
|
$59 Million
3.47% of portfolio
|
Q4 2024
Reduced 13.9%
|
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
1,538,732
shares
|
$56.7 Million
0.03% of portfolio
|
Q4 2024
Added 0.06%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,323,258
shares
|
$48.8 Million
0.01% of portfolio
|
Q4 2024
Added 3.44%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,306,765
shares
|
$48.2 Million
0.01% of portfolio
|
Q4 2024
Added 1.71%
|